Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALCOX stock hub

EPA/ALCOX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALCOXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

33.4M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALCOXEPA/ALCOX

—

Loading chart…

In the news

Latest news · EPA/ALCOX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E2.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-51.2

P25 n/aP50 n/aP75 n/a

ROIC33.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALCOX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

EUR

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	5
Employees Change	-23%
Employees Change Percent	-82.14
Enterprise value	EUR 29.7M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0013018124
Last refreshed	2026-05-10
Market cap	EUR 33.4M
Price	EUR 0.38
Price currency	EUR
Rev Per Employee	3,789,719.4x
Sector	Healthcare
Sic	2834
Symbol	epa/ALCOX
Website	https://www.nicox.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.21%
EV Earnings	-12.31x
EV/EBIT	4.48x
EV/EBITDA	4.47x
EV/Sales	1.57x
Forward P/E	2.92x
P/B ratio	5.56x
P/S ratio	1.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.99%
EBITDA Margin	35.04%
Gross margin	46%
Gross Profit	EUR 8.7M
Net Income	EUR -2.4M
Net Income Growth Years	0%
Pretax Margin	-12.73%
Profit Margin	-12.73%
Profit Per Employee	EUR -482,585
ROA	23.82
Roa5y	-5.71
ROCE	83.67
ROE	-51.16
Roe5y	-76.22
ROIC	33.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-26.46%
Cagr15y	-18.96%
Cagr1y	67.31%
Cagr20y	-20.99%
Cagr3y	-13.33%
Cagr5y	-38.28%
EPS Growth Years	0
Revenue Growth	113.45x
Revenue Growth Q	-11.94x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	27.83x
Revenue Growth5 Y	42.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.09
Assets	EUR 10.4M
Cash	EUR 4.1M
Current Assets	EUR 13.9M
Current Liabilities	EUR 17.6M
Debt	EUR 403,713
Debt EBITDA	EUR 0.06
Debt Equity	EUR 0.07
Equity	EUR 6M
Interest Coverage	2.25
Liabilities	EUR 4.4M
Long Term Assets	EUR -3.5M
Long Term Liabilities	EUR -13.3M
Net Cash	EUR 3.7M
Net Cash By Market Cap	EUR 11.19
Net Debt EBITDA	EUR -0.56
Net Debt Equity	EUR -0.62
Tangible Book Value	EUR 6M
WACC	13.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.17
Net Working Capital	EUR 4M
Quick ratio	3
Working Capital	EUR 7.8M
Working Capital Turnover	EUR 3.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.37%
1Y total return	67.25%
200-day SMA	0.37
3Y total return	-34.91%
50-day SMA	0.42
50-day SMA vs 200-day SMA	50over200
5Y total return	-91.04%
All Time High	480.6
All Time High Change	-99.92%
All Time High Date	2000-03-10
All Time Low	0.14
All Time Low Change	171.07%
All Time Low Date	2024-09-13
ATR	0.02
Beta	0.53
Beta1y	1.86
Beta2y	1.56
Ch YTD	27.35
High	0.38
High52	0.65
High52 Date	2025-08-07
High52ch	-41.62%
Low	0.38
Low52	0.21
Low52 Date	2025-05-16
Low52ch	80.71%
Ma50ch	-9.41%
Price vs 200-day SMA	1.55%
RSI	39.44
RSI Monthly	44.05
RSI Weekly	50.28
Sharpe ratio	1.02x
Sortino ratio	2.18
Tr YTD	27.35
Tr15y	-95.73%
Tr1m	-6.99%
Tr1w	-1.94%
Tr3m	10.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 6.6M
Operating margin	34.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,130,706%
Shares Institutions	6.18%
Shares Out	88,130,706

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	246,730.7x
Ch10y	-95.37
Ch15y	-95.73
Ch1m	-6.99
Ch1w	-1.94
Ch1y	67.25
Ch20y	-99.27
Ch3m	10.64
Ch3y	-34.91
Ch5y	-91.04
Ch6m	18.22
Change	-0.13%
Change From Open	-0.26
Close	0.38
Days Gap	0.13
Depreciation Amortization	9,692
Dollar Volume	59,117.8
Earnings Date	2026-05-14
EBIT	EUR 6.6M
EBITDA	EUR 6.6M
F Score	3
Fiscal Year End	December
Founded	1,996
Is Primary Listing	1
Last Earnings Date	2026-01-23
Last Report Date	2025-06-30
Last Split Date	2015-12-03
Last Split Type	Reverse
Ma150	0.37
Ma150ch	3.63%
Ma20	0.4
Ma20ch	-5.36%
Next Earnings Date	2026-05-14
Open	0.38
Position In Range	12.5
Ppne	8,587
Price Date	2026-05-08
Price EBITDA	EUR 5.04
Ptbv Ratio	5.56
Relative Volume	0.64x
Revenue	18,948,597x
Tr20y	-99.1%
Tr6m	18.22%
Volume	155,778

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALCOX pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALCOX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/ALCOX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EPA/ALCOX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.4

Neutral momentum band

Price vs 200-day MA

+1.6%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALCOX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALCOX stock rating?

epa/ALCOX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALCOX analysis?

The full report lives at /stocks/epa/ALCOX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALCOX?

The latest report frames epa/ALCOX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALCOX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.